Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with <i>Ebf1-Pdgfrb</i> fusion transcriptFrancesca Fazio, Anna Maria Testi, Walter Barberi et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 14
Eltrombopag Added to Standard Immunosuppressive Treatment Improves Long-Term Outcomes As Front-Line Therapy for Severe Aplastic Anemia: Final 2-Year Analysis of EBMT-Saawp Race StudyAntonio M. Risitano, Régis Peffault de Latour, Christian Récher et al.|Blood|2024Cited by 1
<scp>Eltrombopag</scp> Added to Standard Immunosuppressive Treatment as Front‐Line Therapy for Severe Aplastic Anemia: Long‐Term Outcomes of the Phase‐3 Randomized Superiority <scp>EBMT</scp> ‐ <scp>SAAWP RACE</scp> StudyAntonio M. Risitano, Ghulam J. Mufti, Simona Iacobelli et al.|American Journal of Hematology|2026Cited by 0